Pharma & Biopharma Manufacturing
Thermo Fisher Expands U.S. Footprint with New $192.5M Manufacturing Center in North Carolina
Thermo Fisher Scientific Inc., the world leader in serving science, announced the grand opening of its innovative manufacturing center of excellence ...
August 22, 2025 | News
Thermo Fisher Launches Gibco™ Expi293™ PRO System to Transform Protein Expression
Thermo Fisher Scientific has introduced the Gibco™ Expi293™ PRO Expression System, a next-generation HEK293 transient expression system designe...
August 20, 2025 | News
WuXi Biologics Posts Robust H1 2025 Results with Margin Expansion and Record Project Wins
Revenue increased by 16.1% YoY to RMB 9,953.2 million; revenue growth from continuing operations was 20.2% IFRS Gross profit margin expanded b...
August 20, 2025 | Company results
Jiangsu Vcare and Huadong Medicine Form Exclusive Partnership for Commercialization of VC005 Tablets in China
Jiangsu Vcare Pharmatech Co., Ltd. (Jiangsu Vcare) announced that it has entered into an exclusive strategic partnership with Huadong Medicine (H...
August 18, 2025 | News
Fosun Pharma Licenses XH-S004 to Expedition in US$645M Deal
Fosun Pharma announced that its subsidiary Fosun Pharma Industrial has signed a License Agreement with Expedition Therapeutics Inc.(Expedition) t...
August 13, 2025 | News
Sartorius Stedim Biotech Partners with Nanotein to Advance Immune Cell Manufacturing with NanoSpark® Reagents
Nanotein’s NanoSpark® reagents enhance cell activation and expansion in cell therapy manufacturing Exclusive global distribution agreement for...
August 12, 2025 | News
ProBio Launches GMP AAV Manufacturing Services at New Jersey Facility to Accelerate Gene Therapy Development
ProBio, a leading contract development and manufacturing organization (CDMO) specializing in gene and cell therapy, announced the launch of its cGMP Adeno-...
August 12, 2025 | News
RemeGen Secures FDA Clearance for Phase II Trials of Innovative Bispecific Antibody RC148 in Advanced Solid Tumors
RemeGen Co., announces clearance of IND application by Food and Drug Administration (FDA) for phase II clinical trials for its independently-developed bisp...
August 11, 2025 | News
Axplora Invests €6.5 Million to Expand Vizag Facility as USFDA-Cleared Indian Sites Strengthen Global Strategy
Axplora, a global leader in API small molecule manufacturing, today announced a significant investment at its Vizag site in India to expand production ca...
August 06, 2025 | News
Minaris Advanced Therapies opens new GMP manufacturing facility in Munich to boost global cell and gene therapy capabilities
Minaris Advanced Therapies, a leading global contract development and manufacturing organization and testing provider, has announced the opening of its new...
August 05, 2025 | News
WuXi XDC’s New DP3 Facility Achieves GMP Release, Boosting Global Bioconjugate Manufacturing Capacity
WuXi XDC Cayman Inc. ("WuXi XDC", stock code: 2268.HK), a leading global Contract Research, Development and Manufacturing Organization (CRDMO) focused on t...
August 05, 2025 | News
Alveolus Bio Secures Strategic Investment from Shilpa Medicare to Advance Inhaled Microbiome Therapeutics
Alveolus Bio, a pioneering respiratory drug development biotech company founded by Dr. Vivek Lal from University of Alabama at Birmingh...
August 04, 2025 | News
Asahi Kasei to Build New Planova™ Virus Filter Plant in Japan to Meet Surging Biopharma Demand
Asahi Kasei Life Science, a division of diversified global manufacturer Asahi Kasei, announced plans to construct a new spinning plant for its Planova&trad...
July 31, 2025 | News
AGC Biologics Partners with Valneva to Advance Phase II Shigella Vaccine Supply from Heidelberg Site
AGC Biologics, your friendly CDMO expert, announced a development and manufacturing services agreement with specialty vaccine company Valneva SE ...
July 31, 2025 | News
Most Read
- Management of Relapsed/Refractory Multiple Myeloma
- 2025 Drug Approvals, Decoded: What Every Biopharma Leader Needs to Know
- BioPharma Manufacturing Resilience: Lessons From Capacity Expansion and Supply Chain Resets from 2025
- APAC Biopharma Review 2025: Innovation, Investment, and Influence on the Global Stage
- Top 25 Biotech Innovations Redefining Health And Planet In 2025
- How Health Systems Are Reshaping Drug Adoption, Partner Models, and Market Access in 2026
- The New AI Gold Rush: Western Pharma’s Billion-Dollar Bet on Chinese Biotech
- Single-Use Systems Are Rewiring Biopharma Manufacturing
- The State of Biotech and Life Science Jobs in Asia Pacific – 2025
- Asia-Pacific Leads the Charge: Latest Global BioSupplier Technologies of 2025
- Invisible Threats, Visible Risks: How the Nitrosamine Crisis Reshaped Asia’s Pharmaceutical Quality Landscape
Bio Jobs
- The State of Biotech and Life Science Jobs in Asia Pacific – 2025
- Avantor’s New CEO Ligner Aims to Unlock Global Potential and Deliver Shareholder Value
- AstraZeneca Commits $50 Billion to U.S. Expansion by 2030 in Biggest-Ever Global Investment
- Thermo Fisher, SAMRC, and South Africa’s Department of Science and Innovation Launch CATIR to Nurture Next-Gen Scientists
- Cube Biotech Appoints Former Sartorius CEO Dr. Joachim Kreuzburg to Board of Directors
- FDA’s AI Transition Marks a Turning Point in Drug Review: Industry Faces Pressure to Adapt Amid 20% Workforce Cut
- WuXi XDC Completes Mechanical Build of Singapore Bioconjugate Manufacturing Hub
News
Editor Picks
